GlobeNewswire Inc.··NaGrace Therapeutics to Present at TD Cowen Conference; FDA Sets GTx-104 Review Date
Grace Therapeutics will present at TD Cowen conference in March 2026. FDA sets April 2026 review date for GTx-104 aneurysmal subarachnoid hemorrhage treatment.
GRCEFDA approvalclinical-stage